Growth Metrics

Biogen (BIIB) Income towards Parent Company (2016 - 2025)

Biogen has reported Income towards Parent Company over the past 17 years, most recently at -$48.9 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at -$48.9 million for Q4 2025, down 118.34% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 20.79% YoY), and the annual figure for FY2025 was $1.3 billion, down 20.79%.
  • Income towards Parent Company for Q4 2025 was -$48.9 million at Biogen, down from $466.5 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for BIIB hit a ceiling of $1.1 billion in Q3 2022 and a floor of -$134.8 million in Q3 2021.
  • Median Income towards Parent Company over the past 5 years was $395.3 million (2023), compared with a mean of $392.4 million.
  • Biggest five-year swings in Income towards Parent Company: crashed 128.75% in 2021 and later skyrocketed 948.37% in 2022.
  • Biogen's Income towards Parent Company stood at -$101.7 million in 2021, then soared by 649.66% to $559.0 million in 2022, then crashed by 55.47% to $248.9 million in 2023, then rose by 7.15% to $266.7 million in 2024, then plummeted by 118.34% to -$48.9 million in 2025.
  • The last three reported values for Income towards Parent Company were -$48.9 million (Q4 2025), $466.5 million (Q3 2025), and $634.8 million (Q2 2025) per Business Quant data.